Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO SG&A Expense (Annual): 21.02M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.02M |
| December 31, 2022 | 21.95M |
| December 31, 2021 | 18.37M |
| December 31, 2020 | 18.12M |
| December 31, 2019 | 19.91M |
| December 31, 2018 | 14.44M |
| December 31, 2017 | 14.32M |
| Date | Value |
|---|---|
| December 31, 2016 | 12.74M |
| December 31, 2015 | 13.02M |
| December 31, 2014 | 3.998M |
| December 31, 2013 | 0.5461M |
| December 31, 2012 | 0.3393M |
| December 31, 2011 | 0.4853M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
18.12M
Minimum
2020
21.95M
Maximum
2022
19.88M
Average
19.91M
Median
2019
SG&A Expense (Annual) Benchmarks
| XOMA Corp | 25.61M |
| Ironwood Pharmaceuticals Inc | 158.31M |
| CymaBay Therapeutics Inc (DELISTED) | 51.95M |
| Homology Medicines Inc (DELISTED) | 31.26M |
| Amgen Inc | 6.179B |